EPLIN ALS BIOMARKER FÜR KREBS

Patent europeic · EP4133108 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4133108
Numer da la dumonda
EP21723786
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
09-04-2021
Publitgà
15-02-2023
Concedì
29-04-2026
La protecziun finescha il pli tard
08-04-2041
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
C12Q 1/6886 (2018.01)
Prioritad
FI 20205381 09.04.2020
Dumonda PCT
PCT/FI2021/050260 09.04.2021
Publicaziun PCT
WO2021/205078 14.10.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-05-2026

    Represchentant inscrit

    Representative
    Bovard AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 20.05.2026

  2. 29-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 29.04.2026

Partidas

Possessur

THESTRA Oy

c/o Jukka Westermarck Tykistökatu 6A, Turku 20520, FI

Represchentant

Bovard AG

Optingenstrasse 16, 3013 Bern

Inventur

VENTELÄ, Sami

20014 Turun yliopisto, FI

WESTERMARCK, Jukka

20014 Turun yliopisto, FI

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.